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Abstract
DNA methylation is an intensely studied epigenetic mark implicated in many biological pro-
cesses of direct clinical relevance. While sequencing based technologies are increasingly allowing
high resolution measurements of DNA methylation, statistical modelling of such data is still
challenging. In particular, statistical identification of differentially methylated regions (DMRs)
across different conditions poses unresolved challenges in accounting for spatial correlations
within the statistical testing procedure.
We propose a non-parametric, kernel-based method, M3D, to detect higher-order changes
in methylation profiles, such as shape, across pre-defined regions. The test statistic explicitly
accounts for differences in coverage levels between samples, thus handling in a principled way
a major confounder in the analysis of methylation data. Empirical tests on real and simulated
data sets show an increased power compared to established methods, as well as considerable
robustness with respect to coverage and replication levels.
Code is implemented in R, and is freely available via Bioconductor package M3D.
1 Introduction
DNA methylation is an epigenetic mark associated with many fundamental biological processes
of direct clinical relevance, such as imprinting, retrotransposon silencing and cell differentiation
(Gopalakrishnan et al., 2008; Laurent et al., 2010). Methylation occurs when a methyl group is
attached to a cytosine. In mammals, methylation is observed predominantly in the CpG context
and, consequently, studies tend to focus on these loci. The canonical understanding is that methy-
lation of CpG regions (CGIs) in promoter regions is associated with gene silencing, however, recent
studies have shown that CpG methylation correlates with gene expression in a more complex and
context-dependent manner (Varley et al., 2013). Methylation profiles are altered in many diseases,
most notably cancer (Das and Singal, 2004; Sharma et al., 2010), and as such epigenetic therapies
are being developed which specifically target methylation (Yang et al., 2010).
Bisulfite treatment of DNA followed by next generation sequencing provides quantitative methy-
lation data with base pair resolution. Unmethylated cytosines are deaminated into uracils, which
amplify as thymines during PCR (Krueger et al., 2012). Reads are then aligned to a reference
genome, permitting changes of C to T. The resulting counts of cytosine and thymine at registered
cytosine loci form the basis of further analysis. This general procedure has been adapted in various
ways, with reduced representation bisulfite sequencing (RRBS) being one of the most widely used.
RRBS involves using a restriction enzyme such as MspI (or TaqI) to cleave the DNA at CCGG
(or TCGA) loci and selecting short reads for sequencing (Gu et al., 2011). This results in greater
coverage of CpG dense regions at lower cost.
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Several methods have been proposed to statistically test for differentially methylated regions
(DMRs). Almost all of these methods perform a search for DMRs by testing individual cytosines
followed by a post-hoc aggregation procedure. Early methylation studies used Fisher’s Exact
Test (FET) to identify differentially methylated cytosines (DMCs) (Li et al., 2010; Challen et al.,
2012). BSmooth (Hansen et al., 2012), one of the most widely used methods, performs local
likelihood smoothing to generate methylation profiles for each sample, before testing individual
locations in the profiles to identify DMCs. More recent methods, such as BiSeq (Hebestreit et al.,
2013) and methylSig (Park et al., 2014), also employ local smoothing, together with a beta-binomial
model of methylation at individual cytosines; both of these methods then aggregate the results
of tests at individual loci to compute a measure of significance for DMRs. The beta-binomial
method models biological variability at each cytosine location and hence requires a high replication
level to achieve power. Coverage can also be problematic, since low coverage precludes statistical
significance and high coverage can lead to over-confidence in calling DMRs, although the latter
effect can be ameliorated by having a larger number of replicates. For instance, methylSig requires
a minimum of 3 replicates per group and ignores loci which are covered by fewer than 10 reads
by default. A recent method, MAGI (Baumann and Doerge, 2014), takes a different approach
by testing directly for DMRs, rather than computing region-wide measures of significance from
tests of individual cytosines. MAGI assumes the availability of genome-wide decision boundary
methylation levels (which can be determined either from annotation or in a data driven fashion).
Methylation levels at each cytosine are then given a binary representation based on whether they
exceed the decision boundary, and a single FET is performed over each region by counting how
many cytosines have changed state.
While these methods can be highly effective, no current method explicitly accounts for spatial
covariation (MAGI implicitly assumes spatial homogeneity across a region). DNA methylation
levels are often strongly spatially correlated: accounting for such correlations in a testing procedure
could then lead to considerable increases in statistical power. Some examples of spatially correlated
changes in the ENCODE data analysed in Section 3.2 are shown in Figure 1 and Supplementary
Figure S1; notice that in all of these examples the change at individual cytosines is modest, and
hence these regions would not be called as DMRs by currently existing methods. We remark that,
while local smoothing methods like BSmooth (Hansen et al., 2012) attempt to capture spatial
coherence, the local coherence is not an integral part of the testing procedure. Smoothing in
this setting serves the dual purposes of filtering noise and highlighting large scale changes in the
methylation profile. Moreover, the shape of the methylation profile has been suggested as an
important factor in predicting gene expression (VanderKraats et al., 2013), leading to a potentially
functional role for methylation patterns. To our knowledge, there are no methods that test higher
order properties, such as shape, of the methylation profiles over a region.
Here we present Maximum Mean Methylation Discrepancy (M3D), a non-parametric statistical
test for identifying DMRs from pre-defined regions, explicitly accounting for shape changes in
methylation profiles. Our method is based on the maximum mean discrepancy (MMD), a recent
technique from the machine learning literature which tests whether two samples have been generated
from the same probability distribution (Gretton et al., 2007, 2012). Similar non-parametric tests
have already been applied to ChIP-Seq and RNA-Seq data (Schweikert et al., 2013; Drewe et al.,
2013). Our contribution is to adapt the method for the specific challenges of bisulfite sequencing
data, introducing an explicit control for confounding changes in coverage levels. Our method is used
to test for changes in methylation profiles across regions, as opposed to individual cytosines, and
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we call as DMRs those regions whose variation cannot be explained by inter-replicate variability.
We demonstrate the performance of M3D against existing methods on real and simulated data,
showing a considerable increase in power and improved robustness against reduced replication and
coverage levels.
2 Methods
The M3D method is designed to analyse aligned methylation data. Rather than testing individual
cytosines and pooling them into putative DMRs, M3D considers changes in the methylation profile’s
shape over a given region. To quantify shape changes, we compute the MMD over each region and
adjust it to account for changes in the coverage profile across samples. Finally, we use a data-driven
approach to compare test statistics based on the empirical likelihood of observing between-group
differences among replicates. We restrict our analysis to CpGs only and combine data from both
strands.
Selecting which regions to test is an important feature of a differential methylation study, and
must reflect the specific question being asked. Regions can either be pre-defined, such as a list of
promoter regions, or generated from the data by selecting regions of dense CpGs (clusters) as in
[Hebestreit et al., 2013]. We keep this as a flexible option and instead focus on a general framework
for region-based methylation analysis.
2.1 Maximum Mean Discrepancy
Formally, the MMD is defined as follows. Let alF be a class of functions f : X → R over a metric
space X with Borel probability measures p, q. We define the MMD as
MMD[F , p, q] = sup
f∈F
(Ep[f(x)]−Eq[f(x)]) (1)
Intuitively, we are finding the mean over a bounded function that maximises the difference between
the probability distributions. For a sufficiently dense function class, this is equal to 0 if, and only if,
p = q. Choosing F to be the unit ball in a reproducing kernel Hilbert space (RKHS) on X provides
a searchable class of functions that retains this result (Gretton et al., 2007). For x, x′ independent
random variables with distribution p and y, y′ independent random variables with distribution q,
the square of the MMD becomes:
MMD2[F , p, q] = Ep[k(x, x′)]− 2Ep,q[k(x, y)] + Eq[k(y, y′)] (2)
In practice, for X = {x1, ...., xm} , Y = {y1, ..., yn} observations independently and identically
distributed (i.i.d.) from p and q respectively, we can compute a sample-based approximation to the
MMD metric, giving rise to a feature representation in the RKHS, as
MMD[X,Y, k] =
[
Kxx
m2
− 2Kxy
mn
+
Kyy
n2
] 1
2
(3)
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where Kxx =
m∑
i,j=1
k(xi, xj), Kxy =
m,n∑
i,j=1
k(xi, yj),
and Kyy =
n∑
i,j=1
k(yi, yj)
2.2 The M3D statistic
We represent a RRBS data set as a set of vectors xi, where each xi is composed of the genomic loca-
tion of a cytosine Ci, and the methylation status of that Ci on one mapped read, xi = (Ci,Methi).
Thus, there are as many xis in a data set as the number of mapped cytosines (within a CpG con-
text). In order to define an MMD between data sets, we need to define a kernel function operating
on pairs of vectors xi, xj in order to evaluate equation (3). A natural choice is a composite kernel
given by the product of a radial basis function (RBF) kernel on the genomic location and a string
kernel on the methylation status:
kfull(xi, xj) = kRBF (xi, xj)kSTR(xi, xj) (4)
Where kRBF (xi, xj) = exp[−(Ci − Cj)2/2σ2] (5)
and kSTR(xi, xj) =
{
1, if Methi = Methj
0, otherwise
(6)
The RBF kernel, kRBF (xi, xj) retains spatial information at a scale determined by the hyper-
parameter σ, which corresponds to the distance along the genome that displays methylation corre-
lation. We model this parameter independently for each region, R, to reflect the local correlation
structure, as σ2R = x¯
2/2, for x ∈ R, a heuristic suggested in [Gretton et al., 2012]. Here x¯ refers
to the median distance of all observations in region R across the data sets being compared. MMD
distances computed using the above procedure would capture both differences in coverage profiles
and differences in methylation profiles. A particular challenge of bisulfite sequencing data, and a
central tenet of the RRBS procedure (Gu et al., 2011), is that the frequency with which a cytosine
site is tested (the coverage) is unrelated to the methylation status. This poses a challenge in all
bisulfite sequencing analysis, as the sampling distribution becomes a confounding factor in our
attempt to understand methylation. We control for changes in the coverage profile by subtracting
the analogous MMD of the coverage; the M3D metric is then given by:
M3D[X,Y ] = MMD[X,Y, kfull]−MMD[X,Y, kRBF ] (7)
where kfull and kRBF (xi, xj) are as described in equations 4 and 5 and the MMD terms are
as in equation (3). Henceforth, we refer to the the first term, MMD[X,Y, kfull] as the ’full MMD’
and the second term, MMD[X,Y, kRBF ], as the ’coverage MMD’ for convenience.
The last term in equation 7 represents the MMD of the data on a methylation-blind subspace.
This implies that, in the large sample limit when the sample estimate of the MMD converges to
the exact MMD of equation (1), the M3D statistic is non-negative.
The M3D statistic will therefore be different from zero when there is a change in the methylation
profile, independently of a change in the coverage profile. As a consequence, M3D between replicate
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Figure 1: Methylation profiles of CpG clusters uniquely identified by the M3D method in a compar-
ison of leukemia (K562) and ESC cells, section 2.3 & 3.3. DMCs are not individually very different,
yet the profile has changed shape in each case.
RRBS experiments (which do not necessarily have identical coverage) should be close to zero or,
equivalently, the full MMD should be equal to the coverage MMD. This is borne out in the data;
the metrics strongly agree over replicates. Testing equality of metrics over 102 ENCODE RRBS
data sets gives an R2 of 0.95. This can be seen in Supplementary Figure S2; specific examples
can also be seen in Figure 2 (a-c) and Figure 4(a-c), where the dense region around the diagonal
represents unchanged DMRs with M3D close to zero.
2.3 P -value Calculation
We use the M3D as a test-statistic by comparing the values observed across groups to those observed
between replicates. We define our null distribution as the observed M3D values over all of the testing
regions between all replicate pairs. For a given region r, we compute the mean, µr of the M
3D
values over all sample pairs across testing groups for r. The p-value for r is the probability of
observing µr or higher among the null distribution. We use the Benjamini-Hochberg procedure to
calculate false discovery rates (FDRs), rejecting clusters at a 1% significance level (Benjamini and
Hochberg, 1995). Since each test corresponds to an entire region, this correction is less punitive
than methods testing each cytosine location.
In general, we calculate the p-value empirically. In order for the method to scale, we also provide
a model based approximation by fitting an exponential distribution to the 95th percentile of the
null distribution. P -values are calculated in the same manner using the fitted exponential. An
example is shown in Supplementary Figure S3.
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At a given FDR cut-off, identifying DMRs amounts to identifying a threshold M3D value, tfdr
and calling all regions r with µr > tfdr. We find the empirical method to be marginally more
accurate (see Figure 3) and report results with empirically calculated p-values for the rest of this
paper.
3 Data sets
We benchmarked the M3D method on a simulated data set and two real data sets. We briefly
describe here the two real data sets as well as the simulation procedure used. Summary statistics
and figures of the testing regions are shown in section S4 of the Supplementary Data.
3.1 Simulated data
To benchmark the ability of our method to detect true changes without introducing false positives,
we resort to a simulation study. In order to simulate methylation profile changes with realistic
statistics, we constructed our simulation from a real RRBS data set.
We used an RRBS data set of human embryonic stem cells, H1-hESC (described in the following
section), consisting of 2 replicates. Dense CpG regions were identified using the procedure in
(Hebestreit et al., 2013), and for simplicity we focused on the first 1000 on chromosome 1. We
then simulated two more replicates to act as our testing group, as described in section S5 of the
Supplementary Data. The coverage statistics for the resulting data set have a mean of 34.5, and
a median coverage of 23 at each CpG site. We then selectively altered the methylation profile of
randomly chosen regions in the simulated replicates to create known methylation changes and used
the M3D method to test for DMRs.
To simulate methylation changes, we randomly selected 250 of the CpG clusters out of a possible
1000. We selected a short region within each cluster, at least 100bp long and with a total coverage
of at least 100, in each replicate. If necessary, we increased the size of the region until it occupied
at least n CpG sites, where n was uniformly sampled from [4, 20]. The methylation level, Loldi , was
calculated at each cytosine site, Ci as the proportion of all the data points mapping to that site
that were methylated. We measured the mean methylation of the sites and created a simulated
methylation level, Lnewi , by hyper-methylating the region if it was less than 50% methylated on
average, and hypo-methylating it otherwise. The degree of methylation change was controlled by
a parameter α ∈ [0, 1], such that the new methylation level Lnewi = (1 − α)Loldi + α if the region
was being hyper-methylated and Lnewi = (1− α)Loldi if it was being hypo-methylated. To vary the
strength of methylation change, we tested the methods different values of alpha.
Simulated data was then created by sampling data points {x1, ..., xni} at site Ci with corre-
sponding {Meth1, ...,Methni} sampled with probability p(Methj = methylated) = Lnewi , where ni
is the coverage at location Ci. Pseudocode for creating simulated data is shown in Section S5 of
the Supplementary Data.
3.2 Human Data
To test the M3D method on real data, we compared two Tier 1 tracks from the ENCODE consor-
tium, GEO series GSE27584 (ENCODE Project Consortium and others, 2012). RRBS data from
human embryonic stem cells, H1-hESC, were compared against leukemia cells, K562. Both data
sets were produced by the Myers Lab at the HudsonAlpha Institute for Biotechnology. The data
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Table 1: Simulation Results. Sensitivity to low Methylation Changes
Alpha 1 0.8 0.6 0.4
Meth Change (Mean, SD) (0.96, 0.10) (0.76,0.15) (0.57,0.16) (0.38,0.15)
M3D BS MAGI M3D BS MAGI M3D BS MAGI M3D BS MAGI
Correct 232 67 211 231 65 205 210 66 201 197 66 157
Type-1 0 10 2 0 7 2 0 10 2 0 10 0
Type-2 18 183 39 19 185 45 40 184 49 53 184 93
For various values of alpha, we show the corresponding mean and standard deviation of the methylation level
change (the total methylated reads divided by coverage at each CpG) for the altered CpG sites and the results
of testing the three methods. MMD outperforms BSmooth and MAGI .
is available pre-processed and aligned to the hg19 genome, and we used the resulting BED files.
H1-hESC cells came from a human male and K562 from a female, so sex chromosomes were re-
moved from the analysis. Testing regions were defined by clustering CpG sites in the same manner
as for the simulations and regions with no coverage in at least one sample were excluded from the
analysis; this resulted in 14,104 genomic regions for testing.
To investigate the relationship between differential methylation and gene expression, we used the
corresponding 200bp paired end RNA-seq data for H1-ESC and K562 cells available in release 4 of
the ENCODE consortium (ENCODE Project Consortium and others, 2012). Reads were aligned
using TopHat and gene expression estimates in fragments per kilobase of transcript per million
mapped reads (FPKM) were produced with Cufflinks (Trapnell et al., 2012). Gene expression
estimates were averaged across the 3 replicates within each group and analysis was performed on
the resulting changes across groups.
3.3 Mouse Data
We compared a 4 replicate data RRBS data set from mouse strain B6C ESCs (GEO: GSE56572,
Booth et al., 2014) to a 3 replicate data set consisting from sciatic nerve cells from postnatal day
10 (P10) mice (GEO: GSE45343, Varela-Rey et al., 2014). To define testing regions, we used the
list of exons for Mus musculus provided by Ensembl in release 75 (Flicek et al., 2013). We excluded
any exon regions with no coverage in one of the ESC cell samples or with less than 5 CpG sites in
total, leaving 2359 regions in total. Again, data from both strands were combined. The median
coverage at the remaining CpG loci was 24 for the ESCs and 11 for the P10 sciatic nerve cells.
4 Results
4.1 Simulations
We first benchmarked our method on a realistic simulated data set generated as described in Section
3.1. Results were compared against BSmooth and MAGI. BiSeq and methylSig were also considered;
however, since the data set had lower replication than the minimum recommended by the authors,
we decided not to use them. BSmooth was designed for whole genome bisulfite sequencing (WGBS)
data; in order to adapt the method to RRBS data, we followed the authors’ suggestion and altered
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Figure 2: Simulation Results. (a-c) We plot here the coverage MMD against the full MMD metric
for all methods. The M3D test statistic is their difference, the distance in the x-axis from the red
line. Each point is a CpG cluster. Black are unchanged, Green are correctly called DMRs, Blue
are missed DMRs, Red are incorrectly called clusters. (a) M3D identifies a clear relationship and
calls almost all of the clusters. (b) BSmooth calls some of the clusters but makes both types of
error (see Table 1). Classification bears little resemblance to the M3D method. (c) MAGI calls
fewer regions, again with little semblance to the M3D method (d) Histogram of test statistics for
replicate values (blue) and with simulated changes (red), log scale.
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Figure 3: ROC curve. Here we plot the true positive rate against the FDR for each method,
reflecting the proportion of regions called at each FDR. Black is M3D, with empirical p-values,
Blue is M3D with modelled p-values and red is MAGI. AUCs for the methods are 0.99, 0.96 and
0.77 respectively
the maximum allowable distance between neighbouring cytosines before smoothing1. Details for
implementation of BSMooth and MAGI are provided in section S6 of the Supplementary Data.
Figure 2 summarises the results obtained with the methylation strength parameter α (see Sec-
tion 3.1) set to 1. Of the 250 differently methylated regions, the M3D method called 232, with
no falsely called DMRs. Figures 2a-c show scatterplots of coverage MMD on the y axis vs full
MMD on the x axis for all 1000 regions, with colours denoting the results of the testing procedure
using the different statistics. Individual regions are represented as circles, coloured according to
whether the region was a true positive (green), a false positive (red), a false negative (blue) or a true
negative (black). As discussed before, changes in methylation are likely to occur for regions that
are mapped far from the diagonal. The figures show a clear cluster of regions about the diagonal
(the unchanged regions) and a clearly identifiable group with much larger full MMD (the changed
regions). Figure 2a shows the results of the testing procedure using the M3D statistic. As we see,
M3D correctly identifies most of the 250 simulated changes. ROC curves are shown in Figure 3.
Note that BSmooth is omitted as the method does not test regions as a whole, rather identifies
groups of DMCs within the region, and hence does not output a relevant statistic for comparison.
We present the results of BSmooth and MAGI in same framework in 2b-c. BSmooth correctly
called 67 of the regions with an additional 10 false positives, typically calling regions with similar
coverage profile, which we expect is due to the effect of local likelihood smoothing. Figure 2b shows
the BSmooth results; as we see, even regions with very marked shape differences (as quantified by
M3D) were missed, which is to be expected as BSmooth does not include spatial correlations in the
testing procedure. MAGI called 211 of the regions correctly, with 2 false positives (the FDR was
set to 1%). Figure 2c shows that while many of the regions missed had a low M3D statistic, this
was not always the case and there is not a simple relationship between the two methods indicating
that the M3D method performs a genuinely different computation, as opposed to simply being
more powerful. A histogram of the M3D test statistic is shown in Figure 2d for the replicates and
the cross-group comparisons. The empirical testing distribution is shown in blue and is seen to be
consistent around zero and sharply peaked. The simulated DMRs are easily distinguished.
1bioconductor mailing list: https://stat.ethz.ch/pipermail/bioconductor/2013-February/051020.html
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Table 2: Gaussian Bump Simulation
M3D BS MAGI
Correct 190 58 102
Type-1 0 11 1
Type-2 60 192 148
Results for adding a Gaussian bump to the methylation levels. Despite the overall change being
smaller, M3D retains good performance by considering spatial correlations in the data.
We then investigated the sensitivity of our method by systematically altering the strength of the
methylation changes using α = 1, 0.8, 0.6 and 0.4. We compared the M3D method to BSmooth and
MAGI and show our results in Table 2. The M3D method maintains a very creditable performance
level for all of the α values. This is due to the fact that neighbouring cytosines are being altered,
and hence there are spatial correlations in the changes. Were the changes scattered randomly in
the region M3D performance would weaken, whereas MAGI would remain robust. The sudden dip
in performance of MAGI at α = 0.4 is due to fewer of the cytosines’ methylation levels crossing the
threshold value. It is remarkable that at all levels of α the use of the M3D statistic does not lead to
any type I errors, though we note that the other methods have consistent type 2 error levels across
these tests.
To assess the sensitivity of the various methods to spatial correlations, we ran a further simula-
tion, this time adding a ’Gaussian bump’ of to the methylation profiles of the regions, at randomly
chosen locations, with varying widths and strengths. Details are described in Section S5 of the
Supplementary Data. Here we found a more marked contrast in the performance of the methods,
which we show in Table 2. ROC curves are shown in Section S7 of the Supplementary Data.
4.2 Human Data
We now describe the results of comparing two human data sets generated by the ENCODE consor-
tium (see Section 3.2). We focus on three aspects: a general comparison of results between M3D
and BSmooth, an analysis of the robustness of the results with respect to the coverage, and an
analysis of the functional relevance of our results.
4.3 DMR detection.
Out of the 14,104 CpG regions selected for testing (see Section 3.2), M3D identified 4137 DMRs,
and BSmooth and MAGI identified 1649 and 3101 DMRs, agreeing on 1328 and 2353 of the regions
respectively. In Figure 4 we present the results in the same form as Figure 2, where we again see
that the M3D method produces genuinely different results. Figure 4a shows the method applied to
the replicates only, where the methylation-blind and aware metrics agree. Figures 4b and 4c show
the results of between-group testing by M3D and BSmooth respectively. The data has a striking
similarity to Figure 2a; this suggests that, on this real data set, the M3D statistic provides an
excellent measure of changes in methylation profiles. Similarly to the simulated data set, BSmooth
does not behave in a consistent manner with regard to the M3D test-statistic and many CpG
clusters are missed (Figure 4c). A histogram of the M3D test statistics is shown in Figure 4d,
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Figure 4: H1-hESC vs K562 Cells. Black dots are uncalled clusters, red are called. (a) Just
the inter-replicate metrics are shown, for comparison with Figure 2. (b) Between-group clusters
as called by M3D. (c) BSmooth identifies far fewer. Axes show the full and coverage MMD.
Classification bears little resemblance to the M3D method. (d) The histogram of test statistics.
again confirming that the M3D statistics identifies a clear group of changed profiles between the
two conditions. Comparisons to MAGI are shown in section S8 of the Supplementary Data.
4.3.1 Robustness to Low Coverage
To test the consistency of the M3D method to low coverage, we simulated a reduction in the coverage
levels of the H1-hESC and K562 data. We discarded at random reads for the data sets to simulate
a reduction in coverage by 75%, 50% and 25% in both data sets. The M3D method was used to
find DMRs and the results were compared across coverage levels; to alleviate the computational
burden, we only considered CpG regions on chromosome 1.
Of the 1345 CpG clusters on chromosome 1, the M3D method identified 403 DMRs. Reducing
coverage to 75%, 50% and 25% of the original level, the method identified 395, 399 and 386 DMRs
respectively, with 0, 1 and 1 DMRs not in the original set. To see the consistency of the calls, we
show a Venn Diagram in Figure 5. There is a strong overlap in the calls at all levels, indicating
robustness in the method. Interestingly, while fewer regions are called at lower coverage levels,
at each stage we do not see many new regions being called as might be expected. While the
empirical testing distribution is less accurate, the structure remains intact. Both BSmooth and
MAGI showed similar consistency, although the number of regions called was lower in both cases.
Results are shown in section S9 of the Supplementary Data.
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Figure 5: Venn Diagram of Calls with Reduced Coverage. 382 calls are consistent at all coverage
levels. The method misses clusters at lower coverage levels, yet it does not call many DMRs that
weren’t identified at higher coverage levels.
4.3.2 Functional analysis of differential methylation regions.
To investigate the functional relevance of our results, we interpreted the called DMRs in terms of the
functional annotation and expression level of nearby genes. We used three sets of genomic regions,
gene bodies, first exons and promoters; gene and exon regions were downloaded from Ensembl
release 75 (Flicek et al., 2013) and promoter regions were defined as being 2000bp upstream from the
transcription start site (TSS). Tests were run on gene, promoter and first exon regions separately.
We excluded regions with fewer than 5 CpGs and tested the remaining regions for changes in the
methylation profiles using the M3D method.
Since the M3D method provides a measure of the strength, but not direction of the methylation
profile change, we measured the cross group expression change as the absolute value of the FPKM
log-fold change and excluded all genes with less than 100 FPKM in one sample to avoid noise at
low expression levels.
We identified 8747 gene body regions with sufficient expression and CpG content; among these,
the M3D method called 404 as DMRs. We tested the absolute log-fold changes in expression
between called and uncalled regions with a Wilcoxon Rank-Sum test and found the former was
higher (p-value: 2.2 × 10−16). Similarly, 103 of 4916 promoter regions were called as DMRs and
showed an associated higher absolute log-fold expression change (Wilcoxon Rank-Sum test, p-value:
1.18× 10−6). Rather more first exon regions were tested, with 411 of 19473 regions being called as
DMRs. Again, there was an associated increase in the log-fold expression change (Wilcoxon Rank-
Sum test, p-value: 2.2×10−16). None of the 411 first exon DMRs were in the gene bodies of the gene
region testing group, hence this is not a duplicate result. The median log-fold expression change for
genes associated with uncalled regions was 0.15 for gene, promoter and first exon regions. In genes
associated with called promoter regions this rose to 0.24, and in genes and first exon regions the
median was 0.37 and 0.34 respectively (Supplementary Figure S12). These results support earlier
studies outlining a stronger link between methylation in the first exon, as opposed the promoter
region, and gene expression (Brenet et al., 2011).
We performed an enrichment analysis for gene ontology (GO) terms using the Ontologizer
software for the gene, promoter and first exon regions separately (Bauer et al., 2008). In each case,
the population group was chosen to be the set of genes associated with the regions being tested, i.e.
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Figure 6: Venn Diagram of Calls with Fewer Replicates, for the case of 4, 3 and 2 replicates for
ESC cell control group.
those with sufficient coverage and CpG counts, and the study group was the set of genes associated
with the called regions. For this study, we examined the DMRs called by the M3D method against
all of the regions tested, independently of gene expression data. We used parent-child analysis and
adjusted p-values according with a Benjamini-Hochberg procedure at 10% FDR.
For the gene regions, we tested 2,692 called genes against 15,321 tested genes resulting in 208
GO terms being called. Among these, GO terms for embryonic morphogenesis , organ formation,
growth, developmental growth, regulation of cell differentiation, pattern specification process and
cell fate commitment were discovered, as might be expected in a comparison between ESCs and fully
mature K562 cells. This suggests a connection between gene body methylation and cell function.
The first exon group was smaller, with 1,087 called gene associations in a population of 10,811.
31 GO terms were statistically significantly enriched. 24 of these terms were also enriched in the
gene region analysis. Again, terms associated with cell differentiation, such as cell fate specification
and cell fate commitment, were observed. This is striking, since these first exons were not in gene
bodies of the gene testing regions.
The promoter group had 506 gene associations called out of a population of 8,114. Interestingly,
we found no statistically significantly enriched GO terms in the analysis. The top ten enriched GO
terms, by statistical significance are shown in Supplementary Tables 1, 2 and 3 in section 11 for
the three types of genomic regions tested.
4.4 Mouse Data
In order to examine the robustness of the M3D statistic to changes in replication, we considered
a comparison between two mouse data sets with larger replication, the ESCs data set of (Booth
et al., 2014) with four replicates, and the neural data set of (Varela-Rey et al., 2014) with three
replicates. Robustness to low replication is important; as remarked before, while many methods
require at least three replicates in each data set, many experimental protocols (including almost
all of the ENCODE RRBS data) provide only 2 replicates. We used the M3D method to identify
DMRs with 3 and with 2 ESC replicates, and compared the set to those identified with the full 4
ESC replicate sets. DMRs were identified at a 1% FDR.
Of the 2359 exon regions tested, the M3Ds method identified 689, 676 and 609 with methylation
profiles that differed significantly with respect to inter-replicate variation with 4, 3 and 2 replicates
in the ESC group respectively. As is shown in Figure 6, the overlap between the three sets of called
regions accounts for almost 90% of the total. Importantly, while the testing lost power with lower
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replication (as can be expected), only one additional region was called, indicating that the method
does not introduce many false positives with reduced replication levels.
4.5 Computing Times
We report the running times for non-parallel implementations of all methods on the data set used
in sections 3.2 and 4.3. This data set represents a complete RRBS experiment consisting of 14,104
testing regions. On an ordinary desktop PC, MAGI took approximately 30 seconds, BSmooth took
almost 6 minutes (including smoothing) and M3D took approximately 2 hours. The M3D algorithm
is linear in the number of testing regions and combinatorial in the number of replicates.
5 Discussion
We proposed the first kernel-based test for DMRs which exploits higher order spatial features
of methylation profiles. Empirical comparisons on simulated and real data show a considerable
increase in statistical power in comparison with the widely used BSmooth method (Hansen et al.,
2012), as well as considerable robustness to low coverage and low replication. The M3D method
also outperforms MAGI (Baumann and Doerge, 2014) in our simulations, as well as calling more
DMRs in the real data set, though this comes at a computational cost.
The increased power of the M3D approach is due to a number of factors. Firstly, the method
is sensitive to spatially correlated changes in methylation profiles. Methylation profiles are known
to be highly spatially correlated in general, and the results of our experiments imply that spatial
correlation is also a feature of differences in methylation profiles between conditions, at least in
the data sets considered. Secondly, the method explicitly accounts for differences in the coverage
profiles between conditions, a confounding factor for other methods, as demonstrated in Figure 2.
Thirdly, the method models inter-replicate variability on a regional basis along the whole genome.
Each regional cross-group methylation change is compared to this distribution, and test statistics
for each region represent how well the change in methylation profiles can be explained by inter-
replicate variability. At present, other methods that consider inter-replicate variability do so on a
CpG site-by-site basis, which lacks power with low replication and coverage and does not consider
regional, spatial changes. When testing the method with different strengths of methylation change
at CpG loci, we saw a sharp decrease in the number of regions being called as the methylation
profile change over the regions became comparable to inter-replicate variability. Other methods
experienced a less pronounced change in this regard.
Other studies have suggested that changes in shape of methylation profiles are important in
predicting gene expression (VanderKraats et al., 2013). To test whether our method is able to cap-
ture functionally important changes in methylation profiles, we performed gene expression analysis
with human data and showed a link between methylation changes called by the M3D method and
gene expression changes between conditions. Further, the results support the hypothesis that gene
expression is more closely linked to methylation in the first exon of a gene than to methylation
in promoter regions (Brenet et al., 2011). GO analysis of first exon and whole gene methylation
changes both revealed links to cell function, despite none of the exons overlapping the gene regions,
a result that was not apparent for promoter methylation changes. While our findings confirm a
potential role for methylation profile shape as a predictor of gene expression, they do not provide
biological mechanisms for linking methylation shape to gene expression and regulation. While
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sequence variants and protein binding have been shown to be predictive of epigenetic variability
(Gertz et al., 2011; Benveniste et al., 2014), we believe that further investigation of the mechanistic
underpinnings of changes in methylation shape could be a valuable direction for research.
The M3D method provides a considerable increase in power over existing methods, yet it comes
at the cost of computational intensity. In this study we have restricted comparisons to datasets of
low replication, as beta-binomial methods should prove effective with higher replication. We have
also focused on sub-megabase scale changes for two reasons. Firstly, such an analysis is likely to be
exploratory, in the sense that testing regions are not pre-defined, a key requirement for our method,
and secondly, because BSmooth has proved adept at identifying large scale changes in this setting
and is computationally cheaper.
The M3D framework was developed with RRBS data in mind, yet, given its robustness to lower
coverage, we expect that it may also be well suited for WGBS data. In the future, it will be
interesting to develop models that explain the predictive power of methylation profiles in terms of
other epigenetic marks.
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Appendix: Supplementary Data
S1 Further Examples of Unique Calls
Further to the examples of regions uniquely called by the M3D method in section 4.3 (Human Data)
shown in Figure 1 in the main text, we include some more examples of shape based changes called
by the method in Figure S1.
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Figure S1: Examples of regions uniquely called by M3D
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S2 Equality of Metrics
Figure S2 shows a scatter-density plot of the MMD over each region for the coverage data against
the full data for 102 ENCODE RRBS data sets. Testing equality of metrics gives an R2 of 0.95,
and we see some variation, representing inter-replicate variability.
Figure S2: MMD over each region for the coverage kernel against the full kernel for 102 ENCODE
RRBS data sets. There is strong agreement between the metrics.
S3 Model approach to p-values
We fit an exponential distribution to the tail of the empirical distribution (the histogram of M3D
values between replicates), for the 95th percentile. This gives us a value for the exponential pa-
rameter λ, from which we calculate p-value, for a M3D value of x by e−λx (which is 1 minus the
cumulative distribution function).
Figure S3 shows the result of the process. We take a conservative approach and hence over
estimate the p-values.
S4 Testing Regions
S4.1 Simulation
Figure S4 shows histograms of the size of the testing regions for the Simulation.
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Figure S3: Modeling p-values. The black line shows the empirical distribution, the blue shows the
exponential fit. The vertical red line indicates the 95th percentile.
S4.2 Human Data
Figure S5 shows histograms of the size of the testing regions for the Human Data, used in sections
3.2 and 4.3.
S4.3 Mouse Data
Figure S6 shows histograms of the size of the testing regions for the Mouse Data, used in section
3.3 and 4.4.
S4.4 Testing Regions, Called vs Uncalled
In Figure S7, we show histograms of the region length and CpG count for regions that are called
and not called by the M3D method. The histograms in both cases have the same shape, indicating
that there is unlikely to be a bias in the method for calling DMRs. The results come from section
4.3 (Human Data).
S5 Simulation Details
The coverage profile was simulated on a region by region basis. For each region, r we sampled a
’total coverage multiple’, tr from [0.8, 1.2] and a ’weighting variable’ wr from [−0.3, 1.3]. If we call
the coverage profile of the H1-hESC replicates H11 and H12 respectively, we created a coverage
profile for the simulated replicate of region r by taking wr ∗ H11 + (tr − wr) ∗ H12. This was
performed for each simulated replicate.
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(a) CpG Counts (b) Length of Regions
(c) % CpGs changed (d) % region changed by length
Figure S4: Statistics of the testing regions for the Simulation in sections 3.1 and 4.1
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(a) CpG Counts (b) Length of Regions
Figure S5: Statistics of the testing regions for the Human data in sections 3.2, 4.2
(a) CpG Counts (b) Length of Regions
Figure S6: Statistics of the testing regions for the Mouse data in sections 3.3, 4.4
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Figure S7: Statistics of the testing regions uncalled and called regions, from the Human Data
(section 4.3). By region length (bp) and by CpG count.
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A simulated replicate methylation profile was created by finding the mean methylation level of
the H1 replicates at each site and multiplying that by the new coverage in each simulated replicate
(and rounding to ensure integer values were maintained). In the event that the H1 replicates
had low coverage (< 10 reads combined between them) we weighted the methylation level with
a smoothed estimate of the neighbouring cytosines. The resulting coverage profiles had similar
correlations to the inter-replicate values:
Control1 Control2 Sim1 Sim2
Control1 1 0.88 0.84 0.84
Control2 0.88 1 0.87 0.87
Sim1 0.84 0.87 1 0.78
Sim2 0.84 0.87 0.78 1
Below we present the pseudocode describing how we simulated differential methylation in regions
defined by the set truths, for a given value of α, which represents the strength of methylation change.
Algorithm 1 Change the Methylation Profile of Regions in truths
1: for region in truths do
2: Randomly select start locus
3: while CpGs in section < 4 OR section coverage < 100 OR section length <
100bp do
4: Increase section by 1 locus on either side (within region)
5: if length(section) >= length(region)/3 then
6: BREAK
7: end if
8: end while
9: for CpG site i in section do
10: Loldi ← methylation count/coverage at i
11: if Loldi <= 0.5 then
12: Lnewi ← (1− α)Loldi + α
13: else
14: Lnewi ← (1− α)Loldi
15: end if
16: methylation count at i ← sample from ∼ B(coverage at i, Lnewi )
17: end for
18: end for
19:
For the simulation involving adding Gaussian shaped bumps, we used the procedure in algorithm
2. σ, analogous to the variance in a normal distribution, controls the width of the change in bp, and
was drawn uniformly from the integers in the interval [4,100], while the α parameter, representing
the strength of the change was drawn from 0.6,0.8 and 1 with equal probability.
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Algorithm 2 Gaussian Bump: Change the Methylation Profile of Regions in truths
1: for region in truths do
2: Randomly select start locus, l
3: for CpG site i in section do
4: Weighti ← exp[−(i− l)2/σ2]
5: Loldi ← methylation count/coverage at i
6: if Weighted mean over region of Loldi <= 0.5 then
7: Lnewi ← Loldi + α×Weighti
8: else
9: Lnewi ← Loldi − α×Weighti
10: end if
11: Lnewi ← 0 or 1 if below or above resp.
12: methylation count at i ← sample from ∼ B(coverage at i, Lnewi )
13: end for
14: end for
15:
S6 Comparison Methods: Details
BSmooth parameters were chosen to be as low as possible, whilst giving consistent performance
across data sets, a minimum smoothing window (h) of 1000bp, a minimum methylation loci count
(n) of 70, and a maximum gap between sites before smoothing is broken (maxGap) of 1000bp.
These parameters were used for all data sets tested here.
MAGI was implemented as in the paper, using code kindly provided by the authors. The
threshold value for each region was determined by k-means clustering with two clusters, as suggested
in private correspondence from the authors.
An FDR of 1% was used for all methods, for all comparisons.
S7 ROC curves
We present here the ROC curves for the simulation study using Gaussian bumps. We wish to deter-
mine whether pre-defined regions of interest are statistically significantly differentially methylated.
MAGI takes the same approach, and hence a proper comparison is possible. BSmooth, on the
other hand, is primarily a tool for discovering sections of the genome with differential methylation,
relying on testing individual DMCs. The method then creates regions by chaining together CpGs
with t-statistics greater than a threshold (determined from the data). This doesn’t provide single,
comparable statistics, and hence a direct comparison was not possible.
In Figure S9, we show the true positive rate against the FDR, as the method assumed it. Note,
this isn’t the false positive rate, but the attempt to control it. This gives us a sense of the power
of the method to detect DMRs at various FDRs.
We found the are under the curves for the initial simulation to be 0.99, 0.96 and 0.77 for M3D
empirical, M3D modelled and MAGI respectively. For the Gaussian simulation, these were 0.94,
0.84 and 0.77.
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Figure S8: Gaussian Sim
Figure S9: ROC curve for Gaussian simulation. Here we plot ROC curves of the true positive rate
against the controlled FDR for M3D and MAGI. Black is the empirical p-values from M3D, blue is
the modelled p-values, and red is MAGI.
S8 MAGI by M3D statistics
In Figure S10a we plot the calls by MAGI with respect to the M3D statistics, as with Figure 3
in the main text. As noted there MAGI misses approximately a quarter of the calls M3D makes.
These are shown in figure S10b. MAGI calls the regions with a higher M3D statistic in general,
but counterexamples indicate that a fundamentally different process is at work.
S9 BSmooth & MAGI with low Coverage
Figures S11a and S11b show the results of the test for reduced coverage for BSmooth and MAGI
respectively.
S10 Expression Fold Changes
Figure S12 shows histograms for the absolute log-fold change of the called and uncalled regions for
genes, first exons and promoters respectively. All three show an increase, but it is more pronounced
for gene regions and first exons.
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(a) MAGI (b) Calls by M3D, not MAGI
Figure S10: MAGI, Human Data. As with Figure 3 in the main text, we plot the coverage MMD
against the full MMD metric . The M3D test statistic is their difference, the distance in the x-axis
from the red line. Each point is a CpG cluster. Black are unchanged, Green are correctly called
DMRs, Blue are missed DMRs, Red are incorrectly called clusters. In (b) we show the regions
called by M3D but not MAGI.
(a) BSmooth (b) MAGI
Figure S11: Venn Diagram of Calls with Reduced Coverage. (a-b) The methods show broadly
similar consistency to the M3D method with respect to lower coverage.
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Figure S12: Absolute expression log-fold changes for called regions (red) and uncalled regions (blue)
for (a) gene regions, (b) first exon regions and (c) promoter regions.
S11 Gene Ontology Terms
Tables S1, S2 and S3 contain the top ten enriched gene ontology terms for the H1-hESC cells vs
K562 cell comparison study, for gene regions, first exons and promoter regions in Tables S1, S2
and S3 respectively. We include the Benjamini-Hochberg adjusted p-values. Note that none of the
promoter region terms achieve statistical significance, while the gene and first exon terms show a
high degree of overlap.
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Table S1: GO terms: Gene Regions
ID name p.adjusted
1 GO:0071944 cell periphery 1.437708223467503E-25
2 GO:0005886 plasma membrane 6.444067866565821E-22
3 GO:0044459 plasma membrane part 4.062219312427493E-20
4 GO:0032501 multicellular organismal process 3.1909227117764803E-13
5 GO:0044425 membrane part 4.4083353990865556E-13
6 GO:0003677 DNA binding 5.045748555333859E-13
7 GO:0043565 sequence-specific DNA binding 9.122745220828804E-11
8 GO:0044707 single-multicellular organism process 9.790514431161451E-11
9 GO:0004872 receptor activity 1.6558910963111396E-10
10 GO:0022610 biological adhesion 1.6465615260421583E-9
Table S2: GO terms: First Exons
ID name p.adjusted
1 GO:0071944 cell periphery 1.2919365432790091E-5
2 GO:0005886 plasma membrane 5.622471574689E-5
3 GO:0003677 DNA binding 0.0012341786928683266
4 GO:0032501 multicellular organismal process 0.004089560778137887
5 GO:0044459 plasma membrane part 0.0067889743969307675
6 GO:0045165 cell fate commitment 0.0067889743969307675
7 GO:0044707 single-multicellular organism process 0.0067889743969307675
8 GO:0007010 cytoskeleton organization 0.0067889743969307675
9 GO:0022610 biological adhesion 0.00819729130007154
10 GO:0051965 positive regulation of synapse assembly 0.015205197324440567
Table S3: GO terms: Promoter Regions
ID name p.adjusted
1 GO:1990351 transporter complex 0.4262394723222016
2 GO:0006351 transcription, DNA-templated 0.5120415178222222
3 GO:0010977 negative regulation of neuron projection development 0.5261134605589649
4 GO:0044459 plasma membrane part 0.6876369065744885
5 GO:0003677 DNA binding 0.6876369065744885
6 GO:0033764 steroid dehydrogenase activity 0.6876369065744885
7 GO:0007260 tyrosine phosphorylation of STAT protein 0.6876369065744885
8 GO:0006811 ion transport 0.6876369065744885
9 GO:0019825 oxygen binding 0.6876369065744885
10 GO:0080090 regulation of primary metabolic process 0.6876369065744885
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